跳至主要内容
临床试验/PACTR202006539654415
PACTR202006539654415已完成未知

Evaluation of the safety and efficacy of platelet rich plasma in treatment of patients with chronic telogen effluvium: a randomized controlled, patient blind, evaluator blind, clinical trial.

Faculty of Medicine Sohag University0 个研究点目标入组 30 人开始时间: 2020年4月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • female patients
  • chronic telogen effluvium patients (diffuse hair falling more than 6 months)
  • aged between 18 and 55 years

排除标准

  • ?Pregnant and lactating women.
  • ?Patients having any dermatological diseases affecting the scalp.
  • ?Thyroid dysfunction.
  • ?Chronic medical diseases.
  • ?Patients with anemia (hemoglobin level <10mg/dl), thrombocytopenia (platelet count < 100,000 /µL), coagulopathies or patients on anticoagulant therapy as aspirin and patients with iron deficiency.
  • ?Patients received topical or systemic treatment for hair loss in the last three months before the study.

研究者

发起方
Faculty of Medicine Sohag University

相似试验